| Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014 | 2750 | 2014 |
| Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma S Lyford-Pike, S Peng, GD Young, JM Taube, WH Westra, B Akpeng, ... Cancer research 73 (6), 1733-1741, 2013 | 860 | 2013 |
| BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence M Xing, R Liu, X Liu, AK Murugan, G Zhu, MA Zeiger, S Pai, J Bishop Journal of clinical oncology 32 (25), 2718-2726, 2014 | 792 | 2014 |
| Highly prevalent TERT promoter mutations in aggressive thyroid cancers X Liu, J Bishop, Y Shan, S Pai, D Liu, AK Murugan, H Sun, AK El-Naggar, ... Endocrine-related cancer 20 (4), 603-610, 2013 | 700 | 2013 |
| Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas Y Wang, S Springer, CL Mulvey, N Silliman, J Schaefer, M Sausen, ... Science translational medicine 7 (293), 293ra104-293ra104, 2015 | 597 | 2015 |
| Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists JS Lewis Jr, B Beadle, JA Bishop, RD Chernock, C Colasacco, ... Archives of pathology & laboratory medicine 142 (5), 559-597, 2018 | 570 | 2018 |
| p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma JA Bishop, J Teruya-Feldstein, WH Westra, G Pelosi, WD Travis, ... Modern pathology 25 (3), 405-415, 2012 | 490 | 2012 |
| Characterization of HPV and host genome interactions in primary head and neck cancers M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ... Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014 | 445 | 2014 |
| Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method JA Bishop, XJ Ma, H Wang, Y Luo, PB Illei, S Begum, JM Taube, ... The American journal of surgical pathology 36 (12), 1874-1882, 2012 | 391 | 2012 |
| BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis RP Tufano, GV Teixeira, J Bishop, KA Carson, M Xing Medicine 91 (5), 274-286, 2012 | 390 | 2012 |
| Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma JA Bishop, R Sharma, PB Illei Human pathology 41 (1), 20-25, 2010 | 388 | 2010 |
| Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology WC Faquin, LQ Wong, AH Afrogheh, SZ Ali, JA Bishop, M Bongiovanni, ... Cancer cytopathology 124 (3), 181-187, 2016 | 342 | 2016 |
| Human papillomavirus-related carcinomas of the sinonasal tract JA Bishop, TW Guo, DF Smith, H Wang, T Ogawa, SI Pai, WH Westra The American journal of surgical pathology 37 (2), 185-192, 2013 | 322 | 2013 |
| Accurate classification of non–small cell lung carcinoma using a novel microRNA-based approach JA Bishop, H Benjamin, H Cholakh, A Chajut, DP Clark, WH Westra Clinical Cancer Research 16 (2), 610-619, 2010 | 297 | 2010 |
| Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS N Agrawal, Y Jiao, M Sausen, R Leary, C Bettegowda, NJ Roberts, ... The Journal of Clinical Endocrinology & Metabolism 98 (2), E364-E369, 2013 | 286 | 2013 |
| Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in thyroid … R Liu, J Bishop, G Zhu, T Zhang, PW Ladenson, M Xing JAMA oncology 3 (2), 202-208, 2017 | 285 | 2017 |
| Activation of the NOTCH Pathway in Head and Neck Cancer W Sun, DA Gaykalova, MF Ochs, E Mambo, D Arnaoutakis, Y Liu, M Loyo, ... Cancer research 74 (4), 1091-1104, 2014 | 276 | 2014 |
| SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas N Rekhtman, J Montecalvo, JC Chang, D Alex, RN Ptashkin, N Ai, ... Journal of Thoracic Oncology 15 (2), 231-247, 2020 | 253 | 2020 |
| Saliva and plasma quantitative polymerase chain reaction–based detection and surveillance of human papillomavirus–related head and neck cancer SM Ahn, JYK Chan, Z Zhang, H Wang, Z Khan, JA Bishop, W Westra, ... JAMA otolaryngology–head & neck surgery 140 (9), 846-854, 2014 | 247 | 2014 |
| SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity A Agaimy, A Hartmann, CR Antonescu, SI Chiosea, SK El-Mofty, ... The American journal of surgical pathology 41 (4), 458-471, 2017 | 237 | 2017 |
William WestraZweryfikowany adres z jhmi.edu
